Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Unc-93 homolog B7 (UNC93B7) is annotated as a pseudogene in the human genome, meaning it does not encode a functional protein product[1]. There is no evidence in authoritative databases or literature supporting the existence of UNC93B7 as a protein-coding gene, nor as a therapeutic, diagnostic, or biological target. There are no known molecular functions, disease roles, or drug interactions associated with this locus. This distinguishes it from UNC93B1, a functionally relevant ER membrane protein essential for Toll-like receptor (TLR) signaling in immunity[3]. The mention of "UNC93B7" as a molecular target is therefore incorrect and likely due to confusion with other family members or a data entry error. If you intended a different target or need information specifically about the structurally and functionally active UNC93B1 (“Unc-93 homolog B1”), which is involved in TLR signaling and innate immunity, please clarify for further details.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Unc-93 homolog B7 (pseudogene) (UNC93B7).